Compile Data Set for Download or QSAR
maximum 50k data
Found 86 with Last Name = 'goodwin-tindall' and Initial = 'j'
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287566(CHEMBL4160797 | US11572354, Compound 10m)
Affinity DataIC50:  34nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287566(CHEMBL4160797 | US11572354, Compound 10m)
Affinity DataIC50:  34nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287562(CHEMBL4173383 | US11572354, Compound 10e)
Affinity DataIC50:  38nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287562(CHEMBL4173383 | US11572354, Compound 10e)
Affinity DataIC50:  38nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287581(CHEMBL4173791 | US11572354, Compound 10d)
Affinity DataIC50:  100nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287581(CHEMBL4173791 | US11572354, Compound 10d)
Affinity DataIC50:  100nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287567(CHEMBL4165309 | US11572354, Compound 10l)
Affinity DataIC50:  113nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287567(CHEMBL4165309 | US11572354, Compound 10l)
Affinity DataIC50:  113nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287565(CHEMBL4163084 | US11572354, Compound 10c)
Affinity DataIC50:  180nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287565(CHEMBL4163084 | US11572354, Compound 10c)
Affinity DataIC50:  180nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM592245(US11572354, Compound G29)
Affinity DataIC50:  230nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM592244(US11572354, Compound G28)
Affinity DataIC50:  309nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287577(CHEMBL4165466 | US11572354, Compound 10f)
Affinity DataIC50:  322nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287577(CHEMBL4165466 | US11572354, Compound 10f)
Affinity DataIC50:  322nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287569(CHEMBL4177139 | US11572354, Compound 10b)
Affinity DataIC50:  1.25E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287569(CHEMBL4177139 | US11572354, Compound 10b)
Affinity DataIC50:  1.25E+3nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287579(CHEMBL4166936 | US11572354, Compound 9k)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287579(CHEMBL4166936 | US11572354, Compound 9k)
Affinity DataIC50:  2.00E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287561(CHEMBL4163441 | US11572354, Compound 9f)
Affinity DataIC50:  3.81E+3nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287561(CHEMBL4163441 | US11572354, Compound 9f)
Affinity DataIC50:  4.00E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287560(CHEMBL4166521 | US11572354, Compound 10a)
Affinity DataIC50:  4.44E+3nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287560(CHEMBL4166521 | US11572354, Compound 10a)
Affinity DataIC50:  4.44E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287572(CHEMBL4164194 | US11572354, Compound 10g)
Affinity DataIC50:  4.64E+3nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287572(CHEMBL4164194 | US11572354, Compound 10g)
Affinity DataIC50:  4.64E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287582(CHEMBL4174828 | US11572354, Compound 9j)
Affinity DataIC50:  6.00E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287582(CHEMBL4174828 | US11572354, Compound 9j)
Affinity DataIC50:  6.40E+3nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287570(CHEMBL4165816 | US11572354, Compound 9a)
Affinity DataIC50:  1.30E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287570(CHEMBL4165816 | US11572354, Compound 9a)
Affinity DataIC50:  1.36E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287573(CHEMBL4159712 | US11572354, Compound 9h)
Affinity DataIC50:  1.90E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287573(CHEMBL4159712 | US11572354, Compound 9h)
Affinity DataIC50:  1.97E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM592223(US11572354, Compound 9d)
Affinity DataIC50:  2.10E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287575(CHEMBL4175513 | US11572354, Compound 10j)
Affinity DataIC50:  2.10E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287575(CHEMBL4175513 | US11572354, Compound 10j)
Affinity DataIC50:  2.10E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287571(CHEMBL4166900)
Affinity DataIC50:  2.16E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287576(CHEMBL4167644 | US11572354, Compound 10i)
Affinity DataIC50:  2.27E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287576(CHEMBL4167644 | US11572354, Compound 10i)
Affinity DataIC50:  2.27E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287583(CHEMBL4170293 | US11572354, Compound 9b)
Affinity DataIC50:  3.40E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287574(CHEMBL4162371 | US11572354, Compound 9c)
Affinity DataIC50:  3.40E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287574(CHEMBL4162371 | US11572354, Compound 9c)
Affinity DataIC50:  3.42E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287583(CHEMBL4170293 | US11572354, Compound 9b)
Affinity DataIC50:  3.48E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTryptophan 2,3-dioxygenase 2(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287572(CHEMBL4164194 | US11572354, Compound 10g)
Affinity DataIC50:  4.25E+4nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287564(CHEMBL4175924 | US11572354, Compound 10k)
Affinity DataIC50:  4.48E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287564(CHEMBL4175924 | US11572354, Compound 10k)
Affinity DataIC50:  4.48E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM24656(4-PIM | 4-Phenylimidazole | 4-phenyl-1H-imidazole ...)
Affinity DataIC50:  4.80E+4nMAssay Description:Inhibition of human IDO1 expressed in Escherichia coli BL21 (DE3) using L-tryptophan as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedMMDB

TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287584(CHEMBL4170338 | US11572354, Compound 9i)
Affinity DataIC50:  5.00E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287584(CHEMBL4170338 | US11572354, Compound 9i)
Affinity DataIC50:  5.06E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTryptophan 2,3-dioxygenase 2(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287566(CHEMBL4160797 | US11572354, Compound 10m)
Affinity DataIC50:  5.44E+4nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTryptophan 2,3-dioxygenase 2(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287566(CHEMBL4160797 | US11572354, Compound 10m)
Affinity DataIC50:  5.44E+4nMAssay Description:Inhibition of recombinant human 6His-tagged TDO2 expressed in Escherichia coli BL21 (DE3) assessed as reduction in kynurenine production using L-tryp...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTryptophan 2,3-dioxygenase 2(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287581(CHEMBL4173791 | US11572354, Compound 10d)
Affinity DataIC50:  7.01E+4nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
University Health Network

US Patent
LigandPNGBDBM50287568(CHEMBL4172071 | US11572354, Compound 10h)
Affinity DataIC50:  8.33E+4nMAssay Description:Inhibition of recombinant human IDO1 assessed as reduction in kynurenine production using L-tryptophan as substrate after 1 hrMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 86 total ) | Next | Last >>
Jump to: